Optimizing Droplet Digital PCR Assay for Precise Assessment of MEIS1 Gene Promoter Methylation

• Published in: Acta Medica Martiniana Vol. 24; no. 1; pp. 21 - 28
• Main Authors: Samec Marek, Baranova Ivana, Zavhorodnia Iryna, Pec Martin, Pecova Renata, Lucansky Vincent
• Format: Journal Article
• Language: English
• Published: Martin De Gruyter Poland 01-04-2024; Sciendo
• Subjects: Biomarkers; Cancer; ddpcr; DNA methylation; Medical diagnosis; Medical prognosis; meis1; methylation; Polymerase chain reaction; primer design; Sensitivity analysis
• DOI: 10.2478/acm-2024-0004
• EISSN: 1338-4139
• ISSN: 1335-8421

DNA methylation is characterized as a gene regulatory mechanism that involves the methylation of the 5-carbon (C5) position of cytosine, resulting in the formation of 5-methylcytosine. The analysis of aberrantly methylated cytosine-phosphate-guanine (CpG) dinucleotides, primarily in the promoter regions of tumor suppressor genes, can serve as promising prognostic and predictive markers of cancer development. Meis homeobox 1 (MEIS1) gene, crucial for cell growth and differentiation, exhibits dysregulation linked to various cancer types, acting as both a positive and negative regulator. The selection of an appropriate method for the evaluation of gene promoter methylation status is important for clinical implementation without biases regarding false positive and false negative outcomes. The study focuses on the optimization of a novel droplet digital PCR (ddPCR) assay for identifying the methylation status of MEIS1. Compared to traditional methods, ddPCR offers an increased sensitivity and specificity, presenting a promising tool for precise DNA methylation assessment with potential implications for cancer diagnostics and prognostics.